179 related articles for article (PubMed ID: 26264717)
1. Outcome of corticosteroid administration in autoimmune pulmonary alveolar proteinosis: a retrospective cohort study.
Akasaka K; Tanaka T; Kitamura N; Ohkouchi S; Tazawa R; Takada T; Ichiwata T; Yamaguchi E; Hirose M; Arai T; Nakano K; Nei T; Ishii H; Handa T; Inoue Y; Nakata K
BMC Pulm Med; 2015 Aug; 15():88. PubMed ID: 26264717
[TBL] [Abstract][Full Text] [Related]
2. Direct evidence that GM-CSF inhalation improves lung clearance in pulmonary alveolar proteinosis.
Ohashi K; Sato A; Takada T; Arai T; Nei T; Kasahara Y; Motoi N; Hojo M; Urano S; Ishii H; Yokoba M; Eda R; Nakayama H; Nasuhara Y; Tsuchihashi Y; Kaneko C; Kanazawa H; Ebina M; Yamaguchi E; Kirchner J; Inoue Y; Nakata K; Tazawa R
Respir Med; 2012 Feb; 106(2):284-93. PubMed ID: 22112784
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of granulocyte-macrophage colony-stimulating factor therapy in autoimmune pulmonary alveolar proteinosis: a meta-analysis of observational studies.
Khan A; Agarwal R; Aggarwal AN
Chest; 2012 May; 141(5):1273-1283. PubMed ID: 22016491
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune Pulmonary Alveolar Proteinosis Following Pulmonary Aspergillosis.
Arai T; Inoue Y; Akira M; Nakata K; Kitaichi M
Intern Med; 2015; 54(24):3177-80. PubMed ID: 26666607
[TBL] [Abstract][Full Text] [Related]
5. Light chain (κ/λ) ratio of GM-CSF autoantibodies is associated with disease severity in autoimmune pulmonary alveolar proteinosis.
Nei T; Urano S; Itoh Y; Kitamura N; Hashimoto A; Tanaka T; Motoi N; Kaneko C; Tazawa R; Nakagaki K; Arai T; Inoue Y; Nakata K
Clin Immunol; 2013 Dec; 149(3):357-64. PubMed ID: 24211842
[TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of longitudinal response to aerosolized granulocyte-macrophage colony-stimulating factor in two adolescents with autoimmune pulmonary alveolar proteinosis.
Robinson TE; Trapnell BC; Goris ML; Quittell LM; Cornfield DN
Chest; 2009 Mar; 135(3):842-848. PubMed ID: 19265094
[TBL] [Abstract][Full Text] [Related]
7. Duration of benefit in patients with autoimmune pulmonary alveolar proteinosis after inhaled granulocyte-macrophage colony-stimulating factor therapy.
Tazawa R; Inoue Y; Arai T; Takada T; Kasahara Y; Hojo M; Ohkouchi S; Tsuchihashi Y; Yokoba M; Eda R; Nakayama H; Ishii H; Nei T; Morimoto K; Nasuhara Y; Ebina M; Akira M; Ichiwata T; Tatsumi K; Yamaguchi E; Nakata K
Chest; 2014 Apr; 145(4):729-737. PubMed ID: 24158247
[TBL] [Abstract][Full Text] [Related]
8. Better approach for autoimmune pulmonary alveolar proteinosis treatment: inhaled or subcutaneous granulocyte-macrophage colony-stimulating factor: a meta-analyses.
Sheng G; Chen P; Wei Y; Chu J; Cao X; Zhang HL
Respir Res; 2018 Aug; 19(1):163. PubMed ID: 30165864
[TBL] [Abstract][Full Text] [Related]
9. Long-term inhaled granulocyte macrophage-colony-stimulating factor in autoimmune pulmonary alveolar proteinosis: effectiveness, safety, and lowest effective dose.
Papiris SA; Tsirigotis P; Kolilekas L; Papadaki G; Papaioannou AI; Triantafillidou C; Papaporfyriou A; Karakatsani A; Kagouridis K; Griese M; Manali ED
Clin Drug Investig; 2014 Aug; 34(8):553-64. PubMed ID: 24890235
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary alveolar proteinosis: a new autoimmune disease.
Costabel U; Guzman J
Sarcoidosis Vasc Diffuse Lung Dis; 2005 Dec; 22 Suppl 1():S67-73. PubMed ID: 16457018
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic efficacy of granulocyte-macrophage colony-stimulating factor in patients with idiopathic acquired alveolar proteinosis.
Seymour JF; Presneill JJ; Schoch OD; Downie GH; Moore PE; Doyle IR; Vincent JM; Nakata K; Kitamura T; Langton D; Pain MC; Dunn AR
Am J Respir Crit Care Med; 2001 Feb; 163(2):524-31. PubMed ID: 11179134
[TBL] [Abstract][Full Text] [Related]
12. Granulocyte-macrophage colony-stimulating factor inhalation therapy for patients with idiopathic pulmonary alveolar proteinosis: a pilot study; and long-term treatment with aerosolized granulocyte-macrophage colony-stimulating factor: a case report.
Tazawa R; Nakata K; Inoue Y; Nukiwa T
Respirology; 2006 Jan; 11 Suppl():S61-4. PubMed ID: 16423274
[TBL] [Abstract][Full Text] [Related]
13. Reduced GM-CSF autoantibody in improved lung of autoimmune pulmonary alveolar proteinosis.
Ohashi K; Sato A; Takada T; Arai T; Kasahara Y; Hojo M; Nei T; Nakayama H; Motoi N; Urano S; Eda R; Yokoba M; Tsuchihashi Y; Nasuhara Y; Ishii H; Ebina M; Yamaguchi E; Inoue Y; Nakata K; Tazawa R
Eur Respir J; 2012 Mar; 39(3):777-80. PubMed ID: 22379153
[No Abstract] [Full Text] [Related]
14. GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis.
Uchida K; Beck DC; Yamamoto T; Berclaz PY; Abe S; Staudt MK; Carey BC; Filippi MD; Wert SE; Denson LA; Puchalski JT; Hauck DM; Trapnell BC
N Engl J Med; 2007 Feb; 356(6):567-79. PubMed ID: 17287477
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of serum anti-GM-CSF autoantibody levels in autoimmune pulmonary alveolar proteinosis.
Nishimura M; Yamaguchi E; Takahashi A; Asai N; Katsuda E; Ohta T; Ohtsuka Y; Kosaka K; Matsubara A; Tanaka H; Yokoe N; Kubo A; Konno S; Baba K
Biomark Med; 2018 Feb; 12(2):151-159. PubMed ID: 29202602
[TBL] [Abstract][Full Text] [Related]
16. Aerosol granulocyte-macrophage colony-stimulating factor for pulmonary alveolar proteinosis.
Wylam ME; Ten R; Prakash UB; Nadrous HF; Clawson ML; Anderson PM
Eur Respir J; 2006 Mar; 27(3):585-93. PubMed ID: 16507860
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary alveolar proteinosis: time to shift?
Papiris SA; Tsirigotis P; Kolilekas L; Papadaki G; Papaioannou AI; Triantafillidou C; Papaporfyriou A; Karakatsani A; Kagouridis K; Griese M; Manali ED
Expert Rev Respir Med; 2015 Jun; 9(3):337-49. PubMed ID: 25864717
[TBL] [Abstract][Full Text] [Related]
18. Granulocyte-macrophage colony-stimulating factor and lung immunity in pulmonary alveolar proteinosis.
Tazawa R; Hamano E; Arai T; Ohta H; Ishimoto O; Uchida K; Watanabe M; Saito J; Takeshita M; Hirabayashi Y; Ishige I; Eishi Y; Hagiwara K; Ebina M; Inoue Y; Nakata K; Nukiwa T
Am J Respir Crit Care Med; 2005 May; 171(10):1142-9. PubMed ID: 15735059
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies against granulocyte macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosis.
Bonfield TL; Russell D; Burgess S; Malur A; Kavuru MS; Thomassen MJ
Am J Respir Cell Mol Biol; 2002 Oct; 27(4):481-6. PubMed ID: 12356582
[TBL] [Abstract][Full Text] [Related]
20. Occupational inhalational exposure and serum GM-CSF autoantibody in pulmonary alveolar proteinosis.
Xiao YL; Xu KF; Li Y; Li Y; Li H; Shi B; Zhou KF; Zhou ZY; Cai HR
Occup Environ Med; 2015 Jul; 72(7):504-12. PubMed ID: 25995295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
